Interactions at the bilayer interface and receptor site induced by the novel synthetic pyrrolidinone analog MMK3

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 3, 2010, Pages 422-432

  Fotakis, C ^a   Gega, S ^a   Siapi, E ^b   Potamitis, C ^a,b   Viras, K ^a   Moutevelis Minakakis, P ^a   Kokotos, C G ^a   Durdagi, S ^b,c,d   Grdadolnik, S Golic ^e   Sartori, B ^f   Rappolt, M ^f   Mavromoustakos, T ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b INSTITUTE OF BIOLOGY   (Greece)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d UNIVERSITY OF CALGARY   (Canada)

^e NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^f ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

AT1 receptor; Dipalmitoylphosphatidylcholine; Lipid bilayer; MMK3; Partial interdigitation

Indexed keywords

2 PYRROLIDONE DERIVATIVE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPALMITOYLPHOSPHATIDYLCHOLINE; MMK3; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BILAYER MEMBRANE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG PROTEIN BINDING; DRUG STRUCTURE; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; RAMAN SPECTROMETRY; STRUCTURE ANALYSIS; THERMODYNAMICS; X RAY CRYSTALLOGRAPHY;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; CALORIMETRY, DIFFERENTIAL SCANNING; IMIDAZOLES; LIPID BILAYERS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PROTONS; PYRROLIDINES; PYRROLIDINONES; RECEPTORS, ANGIOTENSIN; SPECTRUM ANALYSIS, RAMAN; TEMPERATURE; X-RAY DIFFRACTION;

EID: 76749124055     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.11.009     Document Type: Article

References (74)

1. Pool J.L., Schmieder R.E., Azizi M., Aldigier J.C., Januszewicz A., Zidek W., Chiang Y., and Satlin A. Aliskiren, an orally effective rennin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan. Am. J. Hypert. 20 (2007) 11-20
2. De Gasparo M., Catt K.J., Inagami T., Wright J.W., and Ugner T. The angiotensin II receptors. Pharmacol. Rev. 52 (2000) 415-472
3. Sakarellos C., Lintner K., Piriou F., and Fermandjian S. Conformation of the central sequence of angiotensin II and analogs. Biopolymers 22 (1983) 663-687
4. Matsoukas J.M., Hondrelis J., Keramida M., Mavromoustakos T., Makriyannis A., Yamdagni R., Wu Q., and Moore G. Role of the NH2-terminal domain of ANG II and [Sar1] ANG II on conformation and activity: NMR evidence for aromatic ring clustering and peptide backbone folding compared to [Des1,2,3] ANG II. J. Biol. Chem. 269 (1994) 5303-5312
5. Theodoropoulou E., Mavromoustakos T., Panagiotopoulos D., Matsoukas J., and Smith J. Superimposition of potent non-peptide AT1 receptor antagonists with angiotensin II. Lett. Pept. Sci. 3 (1996) 209-216
6. Matsoukas J.M., Polevaya L., Ancas J., Mavromoustakos T., Kolocouris A., Roumelioti P., Vlahakos D.V., Yamdagni R., Wu Q., and Moore G.J. The design and synthesis of a potent angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone angiotensin II. Bioorg. Med. Chem. Lett. 8 (2000) 1-10
7. Roumelioti P., Tselios T., Alexopoulos K., Mavromoustakos T., Kolocouris A., Moore G.J., and Matsoukas J.M. Structural comparison between type I and type II antagonists: possible implications in the drug design of AT-1 antagonists. Bioorg. Med. Chem. Lett. 10 (2000) 755-758
8. Polevaya L., Mavromoustakos T., Zoumboulakis P., Grdadolnik S.G., Roumelioti P., Giatas N., Mutule I., Keivish T., Vlahakos D., Iliodromitis E., and Kremastinos D. Synthesis and study of cyclic angiotensin II antagonist analogue reveals the role of π*-π* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT1 non-peptide antagonists. Bioorg. Med. Chem. 9 (2001) 1639-1647
9. Roumelioti P., Polevaya L., Zoumpoulakis P., Giatas N., Keivish T., Haritonova A., Zoga A., Vlahakos D., Iliodromitis E., Kremastinos D., Grdadolnik S.G., Mavromoustakos T., and Matsoukas J.M. Design, synthesis and biological evaluation of cyclic angiotensin II analogues with 3,5 side chain bridges: role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non peptide antagonists. Bioorg. Med. Chem. Lett. 12 (2002) 2627-2633
10. Preto M.A.C., Hermani A.M., Maia L.S., Mavromoustakos T., and Ramos M.J. Molecular dynamics simulations of angiotensin II in aqueous and dimethylsulfoxide environments. J. Phys. Chem. B 109 (2005) 17743-17751
11. Matsoukas J.M., Agelis G., Wahhab A., Hondrelis J., Panagiotopoulos D., Yamdagni R., Wu Q., Mavromoustakos T., Maia H.L.S., Ganter R., and Moore G.J. Differences in backbone structure between angiotensin II agonists and type I antagonists. J. Med. Chem. 38 (1995) 4660-4669
12. Mavromoustakos T., Theodoropoulou E., Dimitriou C., Matsoukas J., Panagiotopoulos D., and Makriyannis A. Interactions of angiotensin II with membranes using a combination of differential scanning calorimetry and 31P-NMR spectroscopy. Lett Pept. Sci. 3 (1996) 175-180
13. Mavromoustakos T., Kolocouris A., Zervou M., Roumelioti P., Matsoukas J., and Weisemann R. An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of Nuclear Magnetic Resonance spectroscopy and theoretical calculations. J. Med. Chem. 42 (1999) 1714-1722
14. Zoumpoulakis P., Grdadolnik S.G., Matsoukas J.M., and Mavromoustakos T. Structure elucidation and conformational properties of eprosartan a non peptide Angiotensin II AT1 antagonist. J. Pharm. Biomed. Anal. 28 (2002) 125-135
15. Zoumpoulakis P., Zoga A., Roumelioti P., Giatas N., Grdadolnik S.G., Iliodromitis E., Vlahakos D., Kremastinos D., Matsoukas J.M., and Mavromoustakos T. Conformational and biological studies for a pair of novel synthetic AT1 antagonists. Stereoelectronic requirements for antihypertensive efficacy. J. Pharm. Biomed. Anal. 31 (2003) 833-844
16. Zoumpoulakis P., Politi A., Grdadolnik S.G., Matsoukas J.M., and Mavromoustakos T. Structure elucidation and conformational study of V8. A novel synthetic non peptide AT1 antagonist. J. Pharm. Biomed. Anal. 40 (2006) 1097-1104
17. Mavromoustakos T., Zoumpoulakis P., Kyrikou I., Zoga A., Siapi E., Zervou M., Daliani I., Dimitriou D., Pitsas A., Kamoutsis C., and Laggner P. Efforts to understand the molecular basis of hypertension trough drug:membrane interactions. Curr. Top. Med. Chem. 4 (2004) 445-459
18. Mavromoustakos T., Zervou M., Zoumpoulakis P., Kyrikou I., Benetis N.P., Polevaya L., Roumelioti P., Giatas N., Zoga A., Minakakis P.M., Kolocouris A., Vlahakos D., Grdadolnik S.G., and Matsoukas J.M. Conformation and bioactivity. Design and discovery of novel antihypertensive drugs. Curr. Top. Med. Chem. 4 (2004) 385-401
19. Moutevelis-Minakakis P., Gianni M., Stougiannou H., Zoumpoulakis P., Zoga A., Vlahakos A.D., Iliodromitis E., and Mavromoustakos T. Design and synthesis of novel antihypertensive drugs. Bioorg. Med. Chem. Lett 13 (2003) 1737-1740
20. Mavromoustakos T., Minakakis P.M., Kokotos C.G., Kontogianni P., Politi A., Zoumpoulakis P., Findlay J., Cox A., Balmforth A., Zoga A., and Iliodromitis E. Synthesis, binding studies, and in vivo biological evaluation of novel non-peptide antihypertensive analogs. Bioorg. Med. Chem. 14 (2006) 4353-4360
21. Zoumpoulakis P., Daliani I., Zervou M., Kyrikou I., Siapi E., Lamprinidis G., Mikros E., and Mavromoustakos T. Losartan's molecular basis of interaction with membranes and AT1 receptor. Chem. Phys. Lipids 125 (2003) 13-25
22. Herbette L.G. Pharmacokinetic and pharmacodynamic design of lipophilic drugs based on a structural model for drug-interactions with biological membranes. J. Pestic. Sci. 35 (1992) 363-368
23. Young H.S., Skita V., Mason R.P., and Herbette L.G. Molecular-basis for the inhibition of 1,4-dihydropyridine calcium-channel drugs binding to their receptors by a non-specific site interaction mechanism. Biophys. J. 61 (1992) 1244-1255
24. Rhodes D.G., Newton R., Butler R., and Herbette L. Equilibrium and kinetic studies of the interactions of selmetrol with membrane bilayers. Mol. Pharmacol. 42 (1992) 596-602
25. Mavromoustakos T., Yang D.P., and Makriyannis A. Small angle X-ray diffraction and differential scanning calorimetric studies on O-methyl-(-)-Δ8-Tetrahydrocannabinol and its 5′ iodinated derivative in membrane bilayers. Biochim. Biophys. Acta 1237 (1995) 183-188
26. Tuccinardi T., Ferrarini P.L., Manera C., Ortore G., Saccomanni G., and Martinelli A. Cannabinoid CB2/CB1 selectivity. Recep-1118 tor modeling and automated docking analysis. J. Med. Chem. 49 (2006) 984-994
27. Rumiana K., and Caffrey M. Phases and phase transitions of the phosphatidylcholines. Biochim. Biophys. Acta 1376 (1998) 91-145
28. Tristram-Nagle S., Wiener M.C., Yang C.P., and Nagle J.F. Kinetics of the subtransition in diplamitoylphosphatidylcholine dispersions. Biochemistry 26 (1987) 4288-4294
29. Houslay M.D., and Stanley K.K. Dynamics of Biological Membranes (1982), John Wiley and Sons, New York
30. Rand R.P., Chapman D., and Larsson K. Tilted hydrocarbon chains of dipalmitoyl lecithin become perpendicular to the bilayer before melting. Biophys. J. 15 (1975) 1117-1124
31. Stamatoff J., Feuer B., Guggenheim H.J., Tellez G., and Yamane T. Amplitude of rippling in the PB phase of dipalmitoylphosphatidylcholine bilayers. Biophys. J. 38 (1982) 217-226
32. McIntosh T.J. Differences in hydrocarbon chain tilt between hydrated phosphatidylethanolamine and phosphatidylcholine bilayers: a molecular packing model. Biophys. J. 29 (1980) 237-246
33. Colthup N.B., Daly L.H., and Wiberley S.E. Introduction to Infrared and Raman Spectroscopy. Third Ed. (1990), Academic Press, New York
34. Huang C., Lapides J.R., and Levin I.W. Phase-transition behaviour of saturated, symmetric chain phospholipid bilayers dispersions determined by Raman spectroscopy: correlation between spectral and thermodynamic parameters. J. Am. Chem. Soc. 104 (1982) 5926-5930
35. Levin I.W., and Lewis E.N. Fourier transform Raman spectroscopy of biological materials. Anal. Chem. 62 (1990) 1101A-1111A
36. Pabst G., Rappolt M., Amenitsch H., and Laggner P. Structural information from multilamellar liposomes at full hydration: full q-range fitting with high quality X-ray data. Phys. Rev. E 62 (2000) 4000-4009
37. Netticadan T.J., Ashavaid T.F., and Nair K.G. Characterisation of the canine cardiac sarcolemma in experimental mzocardial ischemia. Indian J. Clin. Biochem. 12 1 (1997) 49-54
38. Trumbore M., Chester W., Moring J., and Rhodes D. Structure and location of amiodarone in a membrane bilayer as determined by molecular mechanics and quantitative X-ray diffraction. Biophys. J. 54 (1988) 535-543
39. Griesinger C., and Ernst R.R. Frequency offset effects and their elimination in NMR rotating-frame cross-relaxation spectroscopy. J. Magn. Reson. 75 (1987) 261-271
40. Sybyl Molecular Modeling Software Package ver. 6.8; Tripos Inc.: St. Louis, MO 63144, 2001.
41. Schuettelkopf A.W., and van Aalten D.M.F. A tool 1049 for high-throughput crystallography of protein-ligand complexes. Acta Cryst.D 60 (2004) 1355-1363
42. Patra M., Karttunen M., Hyvönen M., Falck E., and Vattulainen P. Lipid bilayers driven to a wrong lane in molecular dynamics simulations by subtle changes in long-range electrostatic interactions. J. Phys. Chem. B 108 (2004) 4485-4494
43. Patra M., Karttunen M., Hyvonen M., Falck E., Lindqvist P., and Vattulainen I. Molecular dynamics simulations of lipid bilayers: major artifacts due to truncating electrostatic interactions. Biophys. J. 84 (2003) 3636-3645
44. Lindhal E., Hess B., and van der Spoel D. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J. Mol. Model. 7 (2001) 306-317
45. van Gunsteren W.F., Billeter S.R., Eising A.A., Hunenberger P.H., Kruger P., Mark A.E., Scott W.R.P., and Tironi I.G. Biomolecular simulation: the GROMOS96 manual and user guide, Vdf Hochschulverlag AG an der ETH Zurich (1996), Zurich
46. Berendsen H.J.C., Postma J.P.M., van Gunsteren W.F., Dinola A., and Haak J.R. Molecular dynamics with coupling to an external bath. J. Comput. Chem. 81 (1984) 3684-3690
47. Essmann U., Perera L., Berkowitz M.L., Darden T., Lee H., and Pedersen L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 103 (1995) 8577-8592
48. Parrinello M., and Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. Jpn. J. Appl. Phys. 52 (1981) 7182-7190
49. Hess B., Bekker H., Berendsen H.J.C., and Fraaije J.G.E.M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18 (1997) 1463-1472
50. Humphrey W., Dalke A., and Schulten K. VMD: visual molecular dynamics. J. Mol. Graph. 14 (1996) 33-38
51. Laggner P., and Mio H. SWAX, a dual-detector camera for simulations small and wide-angle X-ray diffraction in polymer and liquid crystal research. Nucl. Instrum. Methods, Phys. Res. A 323 (1992) 86-90
52. Pabst G., Rappolt M., Amenitsch H., and Laggner P. Structural information for multilamellar liposomes at full hydration: full q-range fitting with high-quality X-ray data. Phys. Rev. E 62 (2000) 4000-4009
53. Caillé A. Remarques sur la diffusion des rayons X dans les smectiques. A. C. R. Acad. Sci. Sér. B 274 (1972) 891-893
54. Zhang R., Tristram N.S., Sun W., Headrick R.L., Irving T.C., Suter R.M., and Nagle J.F. Small-angle X-ray scattering from lipid bilayers is well described by modified Caillé theory but not by paracrystalline theory. Biophys. J. 70 (1996) 349-357
55. Hosemann R., and Bagchi S.N. Direct Analysis of Diffraction by Matter (1962), North-Holland publishing Co, Amsterdam
56. Pabst G. Global properties of biomimetic membranes: perspectives on molecular features. Biophys. Rev. Lett. 1 (2006) 57-84
57. Siarheyeva A., Lopez J.J., and Glaubitz C. Localization of multidrug transporter substrates with model membranes. Biochemistry 45 (2006) 6203-6211
58. T. Mavromoustakos, M. Zervou, P. Zoumpoulakis. Design and discovery of novel antihypertensive drugs through conformation and bioactivity studies. Bentham Science Publishers Ltd. Co-Editors:Atta-ur-Rahman, Allen B. Reitz. Associate Editors: M. Iqbal Choundhary, Cheryl P. Kordik. Ur Frontiers in Medicinal Chemistry 3 (2006), 87-113.
59. Silvius J.R., Lyons M., Yeagle P.L., and O'Leary T.J. Thermotropic properties of bilayers containing branched-chain phospholipids, calorimetric, Raman and 31P NMR studies. Biochemistry 24 (1985) 5388-5395
60. O' Leary T.J., Ross P.D., and Levin I.W. Effects of anaesthetic and nonanaesthetic steroids on dipalmitoylphosphatidylcholine liposome: a calorimetric and Raman spectroscopic investigation. Biochemistry 23 (1984) 4636-4641
61. O' Leary T.J., and Levin I.W. Raman spectroscopic study of an interdigitated lipid bilayer dipalmitoylphosphatidylcholine dispersed in glycerol. Biochim. Biophys. Acta 776 (1984) 185-189
62. Wiener M.C., Suter R.M., and Nagle J.F. Structure of the fully hydrated gel phase of diplamitoylphosphatidylcholine. Biophys. J. 55 (1989) 315-325
63. Torbet J.W., and Wilkins M.H.F. X-ray diffraction studies of lecithin bilayers. J. Theor. Biol. 62 (1976) 447-458
64. McIntosh T.J., and Simon S.A. Hydration force and bilayer deformation: a reevaluation. Biochemistry 25 (1986) 4048-4066
65. Petrache H.I., Gouliaev N., Tristram N.S., Zhang R., Suter R.M., and Nagle J.F. Interbilayer interactions from high-resolution X-ray scattering. Phys. Rev. E 57 (1998) 7014-7024
66. Pabst G., Amenitsch H., Kharakoz D.P., Laggner P., and Rappolt M. Structure and fluctuations of phosphatidylcholines in the vicinity of the main phase transition. Phys. Rev. E 70 (2004) 021908
67. Nagle J.F., and Tristram N.S. Structure of lipid bilayers. Biochim. Biophys. Acta 1469 (2000) 159-195
68. 1 receptor: conformational analysis, dynamic NMR spectroscopy, in silico docking and molecular dynamics simulations. J. Chem. Inf. Mod. 49 (2009) 726-739
69. Photakis C., Christodouleas D., Chatzigeorgiou P., Zervou M., Benetis N.P., Vyras K., and Mavromoustakos T. Application of a novel CP-31P NMR methodology to study the possible interdigitation effect of losartan in phospholipids bilayers. Comparison with Raman spectroscopy data. Biophys. J. 96 (2009) 2227-2236
70. Kyrikou I., Daliani I., Mavromoustakos T., Maswadeh H., Demetzos C., Xatziantoniou S., Giatrellis S., and Nounesis G. The modulation of thermal and dynamic properties of vinblastine by cholesterol in membrane bilayers. Biochim. Biophys. Acta 1661 (2004) 1-8
71. Maswadeh H., Demetzos C., Daliani I., Kyrikou I., Mavromoustakos T., Tsortos A., and Nounesis G. A molecular basis explanation of the dynamic and thermal effects of vinblastine sulfate upon dipalmitoylphosphatidylcholine bilayer membranes. Biochim. Biophys. Acta 1567 (2002) 49-55
72. Kyrikou I., Xadjikakou S., Kovala D.D., Viras K., and Mavromoustakos T. Effects of non steroid anti-inflammatory drugs in membrane bilayers containing cholesterol. Chem. Phys. Lipids 132 (2004) 157-169
73. Cantor R.S. The lateral pressure profile in bilayers. Biophys. J. 76 (1999) 2625-2639
74. Xing C., Ollila O.H.S., Vattulainen I., and Olli R. Asymmetric nature of lateral pressure profiles in supported lipid membranes and its implications for membrane protein functions. Soft Matter 5 (2009) 3258-3261